1. Кабаков А.В., Лыков А.П., Морозов Д.В., Казаков О.В., Повещенко А.Ф., Райтер Т.В., Стрункин Д.Н., Коненков В.И. Фенотипическая характеристика химически индуцированной опухоли молочной железы. Бюл. эксперим. биологии и медицины. 2017; 163 (4): 490–493.
Kabakov A.V., Lykov A.P., Morozov D.V., Kazakov O.V., Poveshchenko A.F., Rayter T.V., Strunkin D.N., Konenkov V.I. Phenotypical characteristics of chemically induced mammary tumor. Bull. Exp. Biol. Med. 2017; 163 (4): 490–492. doi: 10.1007/s10517-017-3835-6.
2. Кетлинский С.А., Симбирцев А.С. Цитокины. СПб.: Фолиант, 2008.
Ketlinskiy S.A., Simbirtsev A.S. Cytokines. Sankt-Peterburg: Foliant, 2008. [In Russian].
3. Повещенко А.Ф., Казаков О.В., Орлов Н.Б., Повещенко О.В., Ким И.И., Бондаренко Н.А., Соловьева И.Г., Стрункин Д.Н., Кабаков А.В., Райтер Т.В., Лыков А.П., Богачев С.С., Покушалов Е.А., Коненков В.И. Цитокины лимфы как маркеры онкогенеза и эффективности терапии при экспериментальной опухоли молочной железы крыс WISTAR. Патол. физиология и эксперим. терапия. 2016; 60 (3): 68–75.
Poveshchenko A.F., Kazakov O.V., Orlov N.B., Poveshchenko O.V., Kim I.I., Bondarenko N.A., Solovyova I.G., Strunkin D.N., Kabakov A.V., Rayter T.V., Lykov A.P., Bogachev S.S., Pokushalov E.A., Konenkov V.I. Cytokines of lymph as markers of cancer progression and effectiveness of therapy in experimental breast tumors of rats WISTAR. Patologicheskaya fiziologiya i eksperimental’naya terapiya = Pathological Physiology and Experimental Therapy. 2016; 60 (3): 68–75. [In Russian].
4. Соснина А.В., Великая Н.В., Аутеншлюс А.И. Роль цитокинов в патогенезе злокачественных новообразований. Новосибирск: Вектор-Бест, 2013. 80 с.
Sosnina A.V., Velikaya N.V., Autenshlyus A.I. The role of cytokines in the pathogenesis of malignant neoplasms. Novosibirsk: Vektor-Best, 2013. 80 p. [In Russian].
5. Шипилов М.В., Иванов В.В. Th17-ответ организма при острых респираторных вирусных инфекциях различного генеза. Цитокины и воспаление. 2012; 11 (1): 109–113.
Shipilov M.V., Ivanov V.V. Th17 response of an organism in acute respiratory viral infections of various origins. Tsitokiny i vospalenie = Cytokines and Inflammation. 2012; 11 (1): 109–113. [In Russian].
6. De Luca A., Gallo M., Aldinucci D., Ribatti D., Lamura L., D’Alessio A., de Filippi R., Pinto A., Normanno N. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. J. Cell Physiol 2011; 226 (8): 2131–2138. doi: 10.1002/jcp.22548.
7. De Luca A., Lamura L., Gallo M., Maffia V., Normanno N. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. J. Cell Biochem. 2012; 113 (11): 3363–3370. doi: 10.1002/jcb.24212.
8. Esendagli G., Yilmaz G., Canpinar H., Gunel-Ozcan А., Guc M., Guc D. Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea-induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats. Lab. Animals. 2009; 43 (1): 60–64. doi: 10.1258/la.2008.007076.
9. Harrel M.I., Iritani B.M., Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 2007; 170 (2): 774–786. doi: 10.2353/ajpath.2007.060761.
10. Ikezawa Y., Nakazawa M., Tamura C., Takahashi K., Minami M., Ikezawa Z. Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity. J. Dermatol. Sci. 2005; 39 (2): 105–112. doi: 10.1016/j.jdermsci.2005.02.002.
11. Meneses A., Verastegui E., Barrera J.L., de la Garza J., Hadden J.W. Lymph node histology in head and neck cancer: Impact of immunotherapy with IRX-2. Int. Immunol. 2003; 3 (8): 1083–1091. doi: 10.1016/S1567-5769(03)00017-1.
12. Merendino R.A., Gangemi S., Ruello A., Bene A., Losi E., Lonbardo G., Purello-Dambrosio G. Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations. Int. J. Biol. Markers. 2001; 16 (2): 126–129.
13. Molloy A.P., Martin F.T., Dwyer R.M., Griffin T.P., Murphy M., Barry F.P., O’Brien T., Kerin M.J. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int. J. Cancer. 2009; 124 (2): 326–332. doi: 10.1002/ijc.23939.
14. Sugama S., Conti B. Interleukin-18 and stress. Brain Res. Rev. 2008; 58 (1): 85–95. doi: 10.1016/j.brainresrev.
15. Dhesy-Thind S., Fletcher G.G., Blanchette P.S., Clemons M.J., Dillmon M.S., Frank E.S., Gandhi S., Gupta R., Mates M., Moy B., Vandenberg T., van Poznak C.H. Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: A Cancer Care Ontario and American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol. 2017; 35 (18): 2062–2081. doi: 10.1200/JCO. 2016.70.7257.
16. Su Y.C., Rolph M.S., Cooley M.A., Sewell W.A. Cyclophosphamide augments inflammation by reducing immunosuppression in a mouse model of allergic airway disease. J. Allergy Clin. Immunol. 2006; 117 (3): 635–641. doi: 10.1016/j.jaci.2005.10.042.
17. Takatsu K. Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev. 1998; 9: 25–35.
18. Tsubura A., Lai Y.C., Miki H., Sasaki T., Uehara N., Yuri T., Yoshizawa K. Animal models of N-Methyl-N-nitrosourea-induced mammary cancer and retinal degeneration with special emphasis on therapeutic trials. In Vivo. 2011; 25 (1): 11–22.